Categories
Tags
Authors
Archives
Categories:   All Categories
Suggested keywords
x

What Contract Research Partners Are Best for Running Decentralized or Hybrid Clinical Trials?

How biotech companies can identify the right CRO partner to accelerate patient recruitment, improve trial quality, reduce operational burden and deliv...

Why Global Pharma Needs Concierge Governance for Controlled Regulatory Data

Pharmaceutical organizations are facing a new challenge that goes beyond clinical development, pharmacovigilance and regulatory submissions: controlli...

How Pharmacovigilance Consulting Services Build Scalable PV Systems

Bringing a new therapy to market is one of the most significant milestones in a pharmaceutical or biotechnology company's journey. Yet, while organiza...
Supporting U.S. Biotech Advancing China Originated Drug Assets
The U.S. biopharmaceutical industry is entering a new phase of innovation, one shaped by increasing R&D costs, impending patent expirations and the growing need to strengthen development pipelines through external innovation. As a result, cross-border licensing has become an important strategy for biopharma companies seeking to accelerate drug ...
Five Mistakes Companies Make During eCTD 4.0 Implementation | pharmaREADY®
Five Mistakes Companies Make During eCTD 4.0 Implementation And How to Avoid Them The regulatory landscape is entering one of its most significant periods of transformation since the adoption of electronic submissions. As health authorities worldwide prepare for eCTD 4.0 implementation, pharmaceutical, biotechnology and medical device companies fac...
What to Expect from Pharmacovigilance Services in 2027
Meet Navitas Life Sciences at Pharmacovigilance India 2026 As the pharmaceutical industry embraces artificial intelligence, real-world evidence and increasingly complex global regulations, Pharmacovigilance India 2026 promises to be one of the most influential forums for shaping the future of drug safety. Bringing together regulators, pharmaceutica...
PK Studies in Patients: Choosing the Right Study Design for Faster Drug Development
Drug development begins with one fundamental question: How does the body handle a drug and how does the drug affect the body?The answer comes from pharmacokinetic (PK) and pharmacodynamic (PD) studies, which form the backbone of early clinical development. Whether developing a new molecular entity, a generic drug or a biosimilar, sponsors rely on p...
Data Science: The Competitive Advantage in Modern Drug Development
Boutique by Design. Outcome-focused by Model. As clinical trials become increasingly complex, sponsors need more than functional support, they need expert clinical data science expertise that transforms data into confident decisions. The clinical research industry is entering a new phase of complexity. Global clinical trials are becoming larger, mo...
Full-Service CRO vs FSP: Which Model Is Right for Your Clinical Development Program?
Biotech and pharma companies face increasing pressure to accelerate timelines, manage costs, cater to regulatory changes and maintain quality across global programs. As clinical trials become more complex, selecting the right outsourcing model has become a strategic decision rather than simply an operational one. Among the most widely adopted appro...
How Small Biotechs Can Operate Like Big Pharma Without Big Pharma Budgets
Scientific breakthroughs in oncology, rare diseases, cell and gene therapies, immunology and precision medicine are increasingly being driven by agile and innovative biotech companies rather than pharmaceutical giants alone. Yet many emerging organizations face a familiar challenge: how can they achieve the operational sophistication of large pharm...
25 Years of Navitas Industry Networks Through 25 Voices of Peer Leadership
25 Years in 25 Voices of Peer Leadership For 25 years, the forums and peer networks powered by Navitas Life Sciences have brought together pharmaceutical, biotech, pharmacovigilance and regulatory leaders to exchange ideas, solve complex challenges and support the growth of the life sciences industry. In an industry defined by rapid transformation,...
Advancing Parkinson’s Disease Research Through Smarter Clinical Trial Partnerships
How Foundations, Biotech and Pharma Organizations Can Accelerate Parkinson’s Studies with the Right Clinical Research Partner Parkinson’s disease research is entering a pivotal era. As scientific understanding of neurodegenerative disorders expands, organizations are moving beyond symptom management toward disease modification, precis...
Why End-to-End Clinical Trial Solutions Are Becoming Critical for Global Drug Development
How integrated clinical, regulatory, pharmacovigilance and data science ecosystems are accelerating global development programs Insights ahead of the 2026 DIA China Annual Meeting Global drug development is becoming increasingly complex and sponsors need to manage changing regulatory requirements, decentralized trial models, increasing operational ...

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us